Aspire Biopharma Holdings, Inc. ASBP Q4 2025 Annual earnings
Reported March 30, 2026
Next report
Date not yet announcedVersus estimates
Revenue
Diluted EPS
Ask the moment Aspire Biopharma Holdings, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Aspire Biopharma Holdings, Inc. report Q4 2025 earnings?
- Aspire Biopharma Holdings, Inc. (ASBP) reported Q4 2025 earnings on March 30, 2026.
- What were Aspire Biopharma Holdings, Inc.'s Q4 2025 revenue and EPS?
- Aspire Biopharma Holdings, Inc. reported revenue of $4.3K and diluted EPS of $-1.33 for Q4 2025.
- How did Aspire Biopharma Holdings, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, diluted EPS declined 391.1% from $-0.27.
- Where can I find Aspire Biopharma Holdings, Inc.'s Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001493152-26-013682) directly on SEC EDGAR. The filing index links above go to sec.gov.